Retatrutide shows big weight loss potential but isn’t FDA-approved. Here’s what to know about its safety and legal risks.

People taking GLP-1s had reduced risk for atrial fibrillation, regardless of whether they lost weight or how much they lost, ...

The company's new GLP-1 program will offer both oral and injectable medications Courtesy Amazon Amazon has launched a new GLP ...

Oklahoma researchers found the hormone FGF21 targets the same brain region as GLP-1 drugs, but works by boosting metabolic ...

The company argues the offering is a more comprehensive approach to weight management, allowing patients to receive ongoing ...

Medicare delayed a plan to make insurance companies cover GLP-1 drugs Wegovy and Zepbound. Instead, Medicare will cover the ...

You finally took the plunge and started taking a GLP-1 drug to improve your health. You're keeping up with your GLP-1 pill or ...

The FDA has approved the second GLP-1 pill for overweight and obesity. How does it compare to the Wegovy oral pill?

Experts warn popular GLP‑1 drugs may pose added risks for some patients, highlighting the need for medical supervision.

On Tuesday, Amazon unveiled a new GLP-1 management program aimed at simplifying how patients access, and stay on, high-demand ...

The federal government scrapped a plan to have health insurance companies fund coverage of obesity drugs for seniors, opting ...